Investment Details
Investor Type
Private Investment Firm
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Early Stage, Growth, Late Stage, Pre-IPO, Buyout
Geographical Focus
United States
Industries Focus
- Healthcare
- Biotechnology
Investment Size:
5,000,000 to 50,000,000 USD
Investor Details Founded: 2012
Slate Path Capital is a private investment firm based in New York City, focusing on investments in the healthcare and biotechnology sectors. The firm seeks to identify and support innovative companies that are poised for growth and transformation within these industries.
With a strategic approach, Slate Path Capital invests across various stages, including early-stage ventures, growth companies, late-stage enterprises, pre-IPO opportunities, and buyouts. This diversified strategy enables the firm to tailor its investments to the unique needs and potential of each portfolio company.
The firm's investment philosophy centers on providing substantial capital and strategic guidance to foster innovation and drive value creation in the healthcare and biotechnology sectors. By leveraging its expertise and resources, Slate Path Capital aims to contribute to the advancement of these industries and the success of its portfolio companies.
Requirements
- Innovative business models
- Strong management teams
- Scalable growth potential
- Alignment with healthcare and biotechnology sectors
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- City Therapeutics
Claim this Investor
Are you an official representative of Slate Path Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim